Clinical trials
Terminated Diabetes Mellitus, Type 1 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
193 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 9 |
| 2007 | 14 |
| 2008 | 9 |
| 2009 | 13 |
| 2010 | 10 |
| 2011 | 9 |
| 2012 | 10 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 8 |
| 2016 | 11 |
| 2017 | 9 |
| 2018 | 8 |
| 2019 | 17 |
| 2020 | 7 |
| 2021 | 11 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 193 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rabin Medical Center | 9 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
| Novo Nordisk A/S | 6 |
| Mannkind Corporation | 5 |
| Pfizer | 4 |
| University Hospital, Montpellier | 4 |
| Imperial College London | 3 |
| MacroGenics | 3 |
| Massachusetts General Hospital | 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 193 |
| Diabetes Mellitus | 39 |
| Diabetes Mellitus, Type 2 | 36 |
| Hypoglycemia | 20 |
| Autoimmune Diseases | 7 |
| Insulin Resistance | 5 |
| Asthma | 4 |
| Diabetic Retinopathy | 4 |
| Hyperglycemia | 4 |
| Diabetic Ketoacidosis | 3 |
Trials
Showing 76 to 100 of 193. Each trial links to its page on Pharma Observatory.
93 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.